HK1002610A1 - Method and composition for determining the immunological activity of bioactive substances - Google Patents

Method and composition for determining the immunological activity of bioactive substances Download PDF

Info

Publication number
HK1002610A1
HK1002610A1 HK98101626A HK98101626A HK1002610A1 HK 1002610 A1 HK1002610 A1 HK 1002610A1 HK 98101626 A HK98101626 A HK 98101626A HK 98101626 A HK98101626 A HK 98101626A HK 1002610 A1 HK1002610 A1 HK 1002610A1
Authority
HK
Hong Kong
Prior art keywords
ttp
pbl
ifn
tested
cytokines
Prior art date
Application number
HK98101626A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1002610B (en
Inventor
Inglot Anna
Blach-Olszewska Zofia
Original Assignee
Torf Establishment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Establishment filed Critical Torf Establishment
Publication of HK1002610A1 publication Critical patent/HK1002610A1/en
Publication of HK1002610B publication Critical patent/HK1002610B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK98101626.3A 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances HK1002610B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances
EP91118269 1991-10-26
PCT/EP1992/002228 WO1993008470A1 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Publications (2)

Publication Number Publication Date
HK1002610A1 true HK1002610A1 (en) 1998-09-04
HK1002610B HK1002610B (en) 1998-09-04

Family

ID=

Also Published As

Publication number Publication date
US5543300A (en) 1996-08-06
HU216863B (hu) 1999-09-28
ES2061424T3 (es) 1997-10-01
CZ100494A3 (en) 1994-11-16
SK44094A3 (en) 1995-03-08
EP0609255A1 (en) 1994-08-10
LV12140B (lv) 1998-12-20
DE69220078D1 (de) 1997-07-03
PL170592B1 (en) 1997-01-31
DE539610T1 (de) 1993-12-16
AU2650992A (en) 1993-05-21
LV12140A (lv) 1998-09-20
GR940300077T1 (en) 1994-11-30
DK0609255T3 (da) 1997-12-22
JPH07500905A (ja) 1995-01-26
DE609255T1 (de) 1995-06-14
AU678343B2 (en) 1997-05-29
GR930300100T1 (pm) 1993-10-29
RO114837B1 (ro) 1999-07-30
ATE153763T1 (de) 1997-06-15
BG61705B1 (bg) 1998-03-31
HUT69990A (en) 1995-09-28
RU94022481A (ru) 1996-09-27
BG98720A (bg) 1995-07-28
HU9401185D0 (en) 1994-07-28
ES2061424T1 (es) 1994-12-16
CA2122131A1 (en) 1993-04-29
WO1993008470A1 (en) 1993-04-29
NO941444L (no) 1994-06-16
SG72665A1 (en) 2000-05-23
RU2125727C1 (ru) 1999-01-27
FI941920A7 (fi) 1994-04-25
DE69220078T2 (de) 1997-12-04
GR3024457T3 (en) 1997-11-28
EP0539610A1 (en) 1993-05-05
EP0609255B1 (en) 1997-05-28
FI941920L (fi) 1994-04-25
NO941444D0 (no) 1994-04-21
FI941920A0 (fi) 1994-04-25

Similar Documents

Publication Publication Date Title
Fong et al. Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man.
Weigent et al. Interleukin 2 enhances natural killer cell activity through induction of gamma interferon
EP0609255B1 (en) Method and composition for determining the immunological activity of bioactive substances
Orenstein et al. Prophylaxis of varicella in high-risk children: dose-response effect of zoster immune globulin
US4460574A (en) Prophylaxis or treatment of interferon-sensitive diseases
HILL et al. Recurrent staphylococcal abscesses associated with defective neutrophil chemotaxis and allergic rhinitis
Roberts Jr et al. Hyperthermia and human leukocyte function: II. Enhanced production of and response to leukocyte migration inhibition factor (LIF)
Laszlo et al. Phase I study of pharmacological and immunological effects of human lymphoblastoid interferon given to patients with cancer
US5707814A (en) CD8+ cell antiviral factor
FLEISCHMANN JR et al. Requirement for IFN gamma in potentiation of interferon's antiviral and anticellular activities: identity of mouse and human systems
Rinehart et al. Phase I/II trial of interferon-β-serine in patients with renal cell carcinoma; immunological and biological effects
JPH01110633A (ja) 肝細胞刺激因子
Turco et al. Comparison of the properties of antirickettsial activity and interferon in mouse lymphokines
US4499093A (en) Interferon induction method
Diezel et al. Detection of interferon in the sera of patients with psoriasis, and its enhancement by PUVA treatment
Funa et al. Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon
HK1002610B (en) Method and composition for determining the immunological activity of bioactive substances
Feldman et al. Functional deficiencies in two distinct interferon α-producing cell populations in peripheral blood mononuclear cells from human immunodeficiency virus seropositive patients
Vervliet et al. Interferon production by cultured peripheral leucocytes of MS patients
Ingimarsson et al. Immune Reactions and Long‐Term Therapy with Human Leukocyte Interferon
Torre et al. Increased levels of nitrite in the sera of children infected with human immunodeficiency virus type 1
Bacon et al. Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies
US5565549A (en) CD8+ cell antiviral factor
Einhorn et al. Functions of human neutrophilic granulocytes after in vivo exposure to interferon alpha
Aderka et al. Reduced production of tumor necrosis factor by mononuclear cells in hairy cell leukemia patients and improvement following interferon therapy

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)